Sionna Therapeutics (SION) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Sionna Therapeutics (SION) is Moderate Underperform.

The composite score behind that read is -0.24, weighing +0.28 of bullish evidence against -0.38 bearish.

Sionna Therapeutics last closed at $4.85, -1.22% on the session.

Against the IVW growth benchmark the position is -2.14% over the forecast window.

The read is built from 12 underlying insights — 2 bullish and 10 bearish.

Agreement across those insights is 83%.

16 graded predictions for SION so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Sionna Therapeutics in the 22nd percentile on return on equity, where 100 is best.

Sionna Therapeutics is classified under Health Care / Biotechnology, with a market capitalisation of $221.99M.

StockMap tracks Sionna Therapeutics as the 221st largest of the 344 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 180 Moderate Underperform, 152 Neutral, 11 Strong Underperform and 1 Moderate Outperform.

On that composite Sionna Therapeutics ranks 205th of 344 in the group, against a group median of -0.21.